DOD Biotech PCL (BKK:DOD)

DOD Biotech PCL Revenue

DOD Biotech PCL had revenue of 173.23M THB in the quarter ending March 31, 2025, with 1.60% growth. This brings the company's revenue in the last twelve months to 664.77M, down -10.26% year-over-year. In the year 2024, DOD Biotech PCL had annual revenue of 662.04M, down -4.43%.

• Revenue (ttm): 664.77M
• Revenue Growth: -10.26%
• P/S Ratio: 1.36
• Revenue / Employee: n/a
• Employees: n/a
• Market Cap: 900.83M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	662.04M	-30.67M	-4.43%
Dec 31, 2023	692.71M	144.38M	26.33%
Dec 31, 2022	548.33M	-470.01M	-46.15%
Dec 31, 2021	1.02B	-61.57M	-5.70%
Dec 31, 2020	1.08B	283.99M	35.68%